American National Bank & Trust’s Halozyme HALO Stock Holding History

American National Bank & Trust’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12K	Sell	109 -98	-47%	-$9.46K	﹤0.01%	454
2026 Q2	$16.2K	Hold	207	–	–	﹤0.01%	454
2026 Q1	$13.4K	Sell	207 -153	-43%	-$10.8K	﹤0.01%	461
2025 Q4	$24.2K	Buy	360 +62	+21%	+$4.17K	﹤0.01%	436
2025 Q3	$21.9K	Buy	+298	New	+$19.8K	﹤0.01%	455
2025 Q2	–	Sell	-56	Closed	-$3.57K	–	680
2025 Q1	$3.57K	Buy	+56	New	+$3.25K	﹤0.01%	533

Other funds holding HALO

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

KWM

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $190M AUM 2.75% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $464M AUM 16.89% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

American National Bank & Trust's HALO Position: Q3 2026 in Review

American National Bank & Trust reduced its Halozyme (HALO) stake by 47% in Q3 2026, selling an estimated $9.46K and leaving 109 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

American National Bank & Trust first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. The position peaked at $24.2K in Q4 2025. 85 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

American National Bank & Trust held 109 shares of Halozyme worth $12K as of Q3 2026.
American National Bank & Trust sold 98 Halozyme shares in Q3 2026, an estimated $9.46K.
Halozyme made up ﹤0.01% of American National Bank & Trust's portfolio in Q3 2026, its #454 holding.
American National Bank & Trust first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
American National Bank & Trust's Halozyme position peaked at $24.2K in Q4 2025.
85 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on American National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.